Tags

Type your tag names separated by a space and hit enter

What are the nursing implications when using paliperidone prolonged release for people with schizophrenia.
J Psychiatr Ment Health Nurs. 2008 Dec; 15(10):792-9.JP

Abstract

Paliperidone prolonged release (PR) is a new product licensed for the treatment of schizophrenia. It is the active metabolite of risperidone, a drug that has been successfully used in the treatment of schizophrenia and mood disorder. Paliperidone PR has a unique pharmacological delivery mechanism that may incur benefits for particular patients diagnosed with schizophrenia. Studies investigating paliperidone PR are reviewed along with implications for its use by nurse prescribers and those nurses who monitor the use of medication for people with psychosis.

Authors+Show Affiliations

North Wales NHS Trust, Llwyn-y-Groes Psychiatric Unit, Wrexham, UK. Adrian.Jones@newtr.wales.nhs.uk

Pub Type(s)

Journal Article

Language

eng

PubMed ID

19012670

Citation

Jones, A. "What Are the Nursing Implications when Using Paliperidone Prolonged Release for People With Schizophrenia." Journal of Psychiatric and Mental Health Nursing, vol. 15, no. 10, 2008, pp. 792-9.
Jones A. What are the nursing implications when using paliperidone prolonged release for people with schizophrenia. J Psychiatr Ment Health Nurs. 2008;15(10):792-9.
Jones, A. (2008). What are the nursing implications when using paliperidone prolonged release for people with schizophrenia. Journal of Psychiatric and Mental Health Nursing, 15(10), 792-9. https://doi.org/10.1111/j.1365-2850.2008.01299.x
Jones A. What Are the Nursing Implications when Using Paliperidone Prolonged Release for People With Schizophrenia. J Psychiatr Ment Health Nurs. 2008;15(10):792-9. PubMed PMID: 19012670.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - What are the nursing implications when using paliperidone prolonged release for people with schizophrenia. A1 - Jones,A, PY - 2008/11/18/pubmed PY - 2009/2/14/medline PY - 2008/11/18/entrez SP - 792 EP - 9 JF - Journal of psychiatric and mental health nursing JO - J Psychiatr Ment Health Nurs VL - 15 IS - 10 N2 - Paliperidone prolonged release (PR) is a new product licensed for the treatment of schizophrenia. It is the active metabolite of risperidone, a drug that has been successfully used in the treatment of schizophrenia and mood disorder. Paliperidone PR has a unique pharmacological delivery mechanism that may incur benefits for particular patients diagnosed with schizophrenia. Studies investigating paliperidone PR are reviewed along with implications for its use by nurse prescribers and those nurses who monitor the use of medication for people with psychosis. SN - 1365-2850 UR - https://www.unboundmedicine.com/medline/citation/19012670/What_are_the_nursing_implications_when_using_paliperidone_prolonged_release_for_people_with_schizophrenia_ L2 - https://doi.org/10.1111/j.1365-2850.2008.01299.x DB - PRIME DP - Unbound Medicine ER -